Catálogo de publicaciones - revistas
Science
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
No disponibles.
Disponibilidad
| Institución detectada | Período | Navegá | Descargá | Solicitá |
|---|---|---|---|---|
| No detectada | desde mar. 1997 / hasta dic. 2023 | Science Journals |
Información
Tipo de recurso:
revistas
ISSN impreso
0036-8075
ISSN electrónico
1095-9203
Editor responsable
American Association for the Advancement of Science (AAAS)
País de edición
Estados Unidos
Fecha de publicación
1880-
Cobertura temática
Tabla de contenidos
Getting from One to Two
G. Riddihough
Palabras clave: Multidisciplinary.
Pp. 637-637
All Eyes on Epigenetics
P. A. Kiberstis
Palabras clave: Multidisciplinary.
Pp. 637-637
Around the World
<jats:p>In science news around the world this week, a senator is questioning the FDA about its actions in response to a lawsuit brought by whistleblowers, an Indiana creationism bill is unlikely to advance, Russian space scientists may build a new version of the failed Fobos-Grunt sample return spacecraft, the genome of an extinct human is now online, the Kavli Foundation is endowing its first institute in Japan, Minnesota began destroying blood samples collected in its newborn-screening program, scientists are boycotting Elsevier to protest its journal pricing, and a report outlines the steps needed to increase the number of U.S. science degrees.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 640-642
This Week's Section
<jats:p> Follow the links below for a roundup of the week's top stories in science, or <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencemag.org/content/335/6069/640.1.full.pdf">download a PDF of the entire section</jats:ext-link> . <jats:list list-type="bullet"> <jats:list-item> <jats:p> <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencemag.org/content/335/6069/640.2.summary">Around the World</jats:ext-link> </jats:p> </jats:list-item> <jats:list-item> <jats:p> <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencemag.org/content/335/6069/findings.full">Findings</jats:ext-link> </jats:p> </jats:list-item> <jats:list-item> <jats:p> <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencemag.org/content/335/6069/641.summary">Random Samples</jats:ext-link> </jats:p> </jats:list-item> </jats:list> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 640-643
Random Sample
<jats:p>From 20 to 22 April, the winners of GE's 2011 IN Cell Analyzer Image Competition will appear on NBC Universal's high-definition screen of Times Square in New York City. On 2 February, scientists at the Paranal Observatory in Chile for the first time successfully linked all four telescopes of the Very Large Telescope array. Alan Stern, the principal investigator of NASA's New Horizons mission to the dwarf planet, and Dan Durda, an astronomer and space artist, have posted a petition on the website change.org urging the U.S. Postal Service to issue an official stamp in 2015 honoring the mission's arrival at Pluto. And this week's numbers quantify the annual cost of a new cystic fibrosis drug and the amount raised for pediatric cancer research at a disco dance party.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 641-643
Study Fails to Find Arsenic in Microbial DNA
Palabras clave: Multidisciplinary.
Pp. 642-642
Telltale Isotopes Hint at North Korea Weapons Test
Palabras clave: Multidisciplinary.
Pp. 643-643
New Malaria Death Toll Disputed
Palabras clave: Multidisciplinary.
Pp. 643-643
€22 Billion Stimulus Brings Worries About Egalité
Barbara Casassus
<jats:p>On 3 February, French Prime Minister Francois Fillon announced five new winners in the €7.7 billion Excellence Initiatives, which aims to help create a group of five to 10 world-class research and higher education clusters.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 644-645
New Cystic Fibrosis Drug Offers Hope, at a Price
Jocelyn Kaiser
<jats:p>The new cystic fibrosis drug Kalydeco illustrates both the promise and peril of personalized medicine: It is extremely expensive and helps only 4% of people with the disease, or 1200 patients.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 645-645